| Literature DB >> 26191449 |
Liam Trevithick1, Jon Painter1, Patrick Keown1.
Abstract
Aims and method This paper investigates the relationship between cluster (Mental Health Clustering Tool, MHCT) and diagnosis in an in-patient population. We analysed the diagnostic make-up of each cluster and the clinical utility of the diagnostic advice in the Department of Health's Mental Health Clustering Booklet. In-patients discharged from working-age adult and older people's services of a National Health Service trust over 1 year were included. Cluster on admission was compared with primary diagnosis on discharge. Results Organic, schizophreniform, anxiety disorder and personality disorders aligned to one superclass cluster. Alcohol and substance misuse, and mood disorders distributed evenly across psychosis and non-psychosis superclass clusters. Two-thirds of diagnoses fell within the MHCT 'likely' group and a tenth into the 'unlikely' group. Clinical implications Cluster and diagnosis are best viewed as complimentary systems to describe an individual's needs. Improvements are suggested to the MHCT diagnostic advice in in-patient settings. Substance misuse and affective disorders have a more complex distribution between superclass clusters than all other broad diagnostic groups.Entities:
Year: 2015 PMID: 26191449 PMCID: PMC4478925 DOI: 10.1192/pb.bp.114.047043
Source DB: PubMed Journal: BJPsych Bull ISSN: 2056-4694
Discharges from each cluster and the percentage in the likely, unlikely and other diagnoses from the Mental Health Clustering Tool advice. Individual clusters with low rates of ‘likely’ diagnosis and high rates of ‘other’ diagnoses in bold
| Diagnoses, % | ||||
|---|---|---|---|---|
| Cluster | Total number | Likely | Unlikely | Other |
| Non-psychosis (1–8) | 896 | 59 | 9 | 32 |
| 1 | 4 | N/A | N/A | N/A |
| 2 | 17 | N/A | N/A | N/A |
| | ||||
| | ||||
| 5 | 151 | 68 | 7 | 25 |
| 6 | 67 | 75 | 9 | 16 |
| 7 | 157 | 65 | 10 | 25 |
| 8 | 239 | 62 | 10 | 28 |
| Psychosis (10–17) | 899 | 73 | 10 | 17 |
| | ||||
| 11 | 111 | 74 | 17 | 9 |
| 12 | 169 | 76 | 15 | 9 |
| 13 | 102 | 83 | 6 | 11 |
| 14 | 220 | 74 | 10 | 16 |
| | ||||
| 16 | 80 | 81 | 15 | 4 |
| 17 | 56 | 93 | 4 | 3 |
| Organic (18–21) | 113 | 66 | 3 | 31 |
| | ||||
| 19 | 50 | 68 | 0 | 32 |
| 20 | 32 | 78 | 0 | 22 |
| 21 | 10 | N/A | N/A | N/A |
| Total | 1908 | 66 | 9 | 25 |
Broad ICD-10 diagnostic groups at discharge and superclass cluster group at admission
| Superclass cluster groups | |||||
|---|---|---|---|---|---|
| Cluster | Non- | Psychosis | Organic | Total | |
| F00–09 Dementia and organic disorders | 5 (4) | 10 (8) | 14 (12) | 92 (76) | 121 (100) |
| F10–19 Substance misuse | 3 (1) | 128 (56) | 93 (40) | 6 (3) | 230 (100) |
| F20–29 Schizophrenia and related disorders | 6 (1) | 31 (6) | 445 (92) | 2 (0) | 484 (100) |
| F30–39 Affective disorders | 7 (1) | 255 (49) | 254 (49) | 1 (0) | 517 (100) |
| F40–48 Neurotic, stress-related and somatoform disorders | 3 (1) | 199 (82) | 40 (17) | 0 (0) | 242 (100) |
| F60–69 Personality and behaviour disorders | 2 (1) | 235 (87) | 34 (13) | 0 (0) | 271 (100) |
| Other diagnoses | 2 (3) | 39 (54) | 19 (26) | 12 (17) | 72 (100) |
| Missing diagnostic data | 19 (3) | 248 (39) | 192 (30) | 174 (27) | 633 (100) |
| Total | 47 (2) | 1145 (45) | 1091 (42) | 287 (11) | 2570 (100) |
| χ2 = 1622.7, d.f. = 14, | |||||
The distribution of F10–19 substance misuse and F30–39 affective disorder diagnoses across the non-psychosis and psychosis superclass groups. Cluster 0 and organic superclass are not shown separately, but are included in total numbers
| MHCT groups | |||
|---|---|---|---|
| ICD-10 diagnostic group | Total cluster 1–8 | Total cluster 10–17 | Total |
| F10–19 alcohol and substance misuse | 128 (56%) | 93 (40%) | 230 (100%) |
| F10 alcohol | 80 (67%) | 31 (26%) | 119 (100%) |
| F11–18 opioids, cannabinoids, sedatives, stimulants etc. | 7 (29%) | 16 (67%) | 24 (100%) |
| F19 multiple drug use | 41 (47%) | 46 (53%) | 87 (100%) |
| χ2 = 20.41, d.f. = 2, | |||
| F30–39 affective disorder | 255 (49%) | 254 (49%) | 517 (100%) |
| F30–31 mania and bipolar disorder | 49 (20%) | 192 (78%) | 245 (100%) |
| F32–33 depression | 196 (76%) | 59 (23%) | 259 (100%) |
| F34–39 persistent mood disorders, other mood disorders | 10 (77%) | 3 (23%) | 13 (100%) |
| χ2 = 162.22, d.f. = 2, | |||
| F31 bipolar disorder | |||
| with psychotic symptoms | 8 (19%) | 34 (79%) | 43 (100%) |
| without psychotic symptoms | 20 (29%) | 48 (69%) | 70 (100%) |
| mixed episode | 2 (15%) | 11 (85%) | 13 (100%) |
| unspecified | 16 (14%) | 97 (85%) | 114 (100%) |
| χ2 = 6.46, d.f. = 2, | |||
| F32 and F33 depression | |||
| with psychotic symptoms | 22 (38%) | 35 (60%) | 58 (100%) |
| without psychotic symptoms | 93 (86%) | 13 (12%) | 108 (100%) |
| unspecified | 81 (88%) | 11 (12%) | 92 (100%) |
| χ2 = 60.45, d.f. = 2, | |||